Nucala

Nucala (mepolizumab) is a monoclonal antibody that helps the body’s immune system by reducing the level of a certain type of white blood cells. Specifically it is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) for patients with severe eosinophilic asthma and patients with eosinophilic granulomatosis polyangiitis (EGPA).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.